Form 4 for NEO NEOGENOMICS INC
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-21 · accession 0001077183-21-000260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-22 | NEO | McKenzie Kathryn B | CFO | M - OptEx | $9.07 | +5,000 | 16.7K | +43% | +$45.4K |
| D | 2021-12-23 | 2021-12-21 | NEO | McKenzie Kathryn B | CFO | S - Sale+OE | $35.00 | -1,846 | 11.7K | -14% | -$64.6K |
| D | 2021-12-23 | 2021-12-22 | NEO | McKenzie Kathryn B | CFO | M - OptEx | $0.00 | -5,000 | 20.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 5,000 | $9.07 | 16,689 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-21 | S | D | 1,846 | $35.00 | 11,689 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 5,000 | $0.00 | 20,000 | D | $9.07 · — to 2022-10-18 | 5,000 Common Stock | (F2) On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date |